Sermorelin 5 mg

DRAGON PHARMA SERMORELIN

Dragon Pharma Sermorelin 5 mg offers a sophisticated and physiological approach to boosting your body's natural growth hormone (GH) production. Unlike direct GH injections that can suppress your pituitary gland and cause unwanted side effects like water retention and insulin resistance, Sermorelin works with your body's own regulatory systems. As a synthetic analog of Growth Hormone-Releasing Hormone (GHRH), it signals your pituitary gland to produce and release more of your endogenous GH in the natural, pulsatile pattern that evolution designed. For bodybuilders, athletes, and fitness enthusiasts in the USA, this means accessing the powerful benefits of increased GH—enhanced recovery, improved sleep, deeper fat burning, and better skin and joint health—without the drawbacks of exogenous hormone use. Dragon Pharma's pharmaceutical-grade 5 mg vial provides a potent and reliable dose of this key peptide, making it an essential tool for those seeking to optimize performance, body composition, and overall vitality through natural hormonal enhancement. Whether used alone or in synergistic stacks, Sermorelin represents a smarter, more sustainable path to leveraging the power of growth hormone.

DRUG COMPOSITION

Each vial contains 5 mg of highly purified Sermorelin acetate. Sermorelin is a 29-amino acid peptide fragment (positions 1-29) of the endogenous 44-amino acid Growth Hormone-Releasing Hormone (GHRH). Its sequence is: H-Tyr-Ala-Asp-Ala-Ile-Phe-Thr-Asn-Ser-Tyr-Arg-Lys-Val-Leu-Gly-Gln-Leu-Ser-Ala-Arg-Lys-Leu-Leu-Gln-Asp-Ile-Met-Ser-Arg-NH2. The acetate salt enhances stability. The formulation is 100% active peptide, presented as a sterile, white lyophilized powder without preservatives or fillers.

PHARMACEUTICAL FORM

Sterile, white to off-white lyophilized (freeze-dried) powder in a multi-dose 2 mL glass vial. The vial is sealed with a bromobutyl rubber stopper and an aluminum crimp cap to ensure sterility. Requires reconstitution with Bacteriostatic Water prior to subcutaneous injection.

PHARMACEUTICAL GROUP AND ATC CODE

Sermorelin is classified as a Growth Hormone-Releasing Hormone (GHRH) analog. It belongs to the pharmacological class of hypothalamic hormones. Its Anatomical Therapeutic Chemical (ATC) classification is H01AC04 - Somatropin agonists, specifically under the subcategory of growth hormone-releasing factors.

PHARMACOLOGICAL PROPERTIES

Sermorelin exerts its effects by mimicking the action of natural GHRH released from the hypothalamus.

• Pituitary Stimulation: It binds with high affinity to GHRH receptors on somatotroph cells in the anterior pituitary gland.
• Natural GH Pulse Induction: This binding triggers intracellular signaling (via cAMP) that stimulates both the synthesis and the pulsatile secretion of endogenous Growth Hormone. This pulsatile release is crucial; it mimics the body's natural rhythm, which is more effective for fat metabolism and has a lower risk of inducing tolerance compared to constant elevation.
• IGF-1 Production: The released GH travels to the liver and other tissues, stimulating the production of Insulin-like Growth Factor 1 (IGF-1), which mediates many of the anabolic and growth-promoting effects.
• Key Benefits of Increased GH/IGF-1:
  • Enhanced Protein Synthesis & Recovery: Promotes repair of muscle tissue, ligaments, and tendons.
  • Increased Lipolysis: Stimulates the breakdown of stored fat, particularly visceral fat.
  • Improved Sleep Quality: GH is primarily released during deep sleep (slow-wave sleep), and Sermorelin can enhance this cycle, leading to more restorative sleep.
  • Collagen Synthesis: Improves skin elasticity, thickness, and wound healing; strengthens connective tissues.
  • Bone Density & Cardiovascular Health: Supports bone mineralization and can have positive effects on cholesterol profiles.
• Physiological Feedback: Importantly, because it stimulates natural release, it is subject to the body's own negative feedback mechanisms (via somatostatin and IGF-1), reducing the risk of GH excess (acromegaly).

THERAPEUTICAL INDICATIONS

For research and performance optimization, Dragon Pharma Sermorelin 5 mg is indicated for:

• Age-Related GH Decline (Somatopause): Counteracting the natural decrease in GH secretion that begins in early adulthood, leading to reduced vitality, increased body fat, and poorer recovery.
• Enhanced Athletic Recovery: Accelerating repair of muscle micro-tears and connective tissues between training sessions, allowing for higher training frequency and volume.
• Body Recomposition: Supporting loss of body fat while preserving or enhancing lean muscle mass, especially when combined with proper diet and exercise.
• Sleep Optimization: Improving the depth and quality of sleep, which is critical for hormonal balance, recovery, and cognitive function.
• Skin Health & Anti-Aging: Reducing the appearance of wrinkles, improving skin texture, and strengthening hair and nails through increased collagen production.
• Joint and Connective Tissue Support: Alleviating minor joint pains and strengthening tendons and ligaments, which is particularly valuable for aging athletes or those using heavy loads.

DOSES AND METHOD OF ADMINISTRATION

• Reconstitution: Add 2-3 mL of Bacteriostatic Water to the 5 mg vial. Gently swirl until completely clear. Do not shake vigorously. This yields a concentration convenient for drawing precise doses.
• Standard Dosage: The typical research dosage for adults is 100 mcg to 300 mcg (0.1 mg to 0.3 mg) administered via subcutaneous injection. A common and effective protocol is 200-250 mcg once daily. The 5 mg vial provides a 16-25 day supply at this dosage.
• Timing: For maximum alignment with the body's natural circadian rhythm, Sermorelin is best injected in the evening, before bedtime (30-60 minutes prior), ideally on an empty stomach or at least 2 hours after eating. This timing potentiates the natural nocturnal GH surge.
• Cycle Length: Sermorelin is typically used in longer cycles due to its role in gradually restoring pituitary function. Common cycles are 3 to 6 months (12 to 24 weeks), often followed by a break of 4-8 weeks to prevent receptor desensitization.
• Administration: Use a sterile insulin syringe for subcutaneous injection into abdominal fat. Rotate injection sites daily. Intramuscular injection is not necessary and offers no advantage for this peptide.

CYCLE/STACKING

Sermorelin is highly stackable, often used as a foundational GHRH in combination protocols.

• With GHRPs for Synergy (The "Secretagogue Stack"): The most powerful combination pairs Sermorelin (a GHRH) with a Growth Hormone-Releasing Peptide like GHRP-2 5 mg or GHRP-6 10 mg. They work on different receptors (GHRH-R vs. GHS-R) and have a multiplicative effect on GH release, greater than the sum of their parts.
• In an Anti-Aging & Longevity Protocol: Combine with Thymosin Alpha-1 10 mg for immune support and SS-31 50 mg for mitochondrial health for a comprehensive cellular rejuvenation stack.
• For Fat Loss & Metabolic Health: Stack with the GLP-1 agonist Semaglutide for appetite control and the metabolic enhancer GW501516 (Cardarine). Sermorelin's lipolytic effects complement these agents beautifully.
• During a Healing/Recovery Phase: Use alongside healing peptides like TB 500 and BPC 157. The increased GH from Sermorelin provides the systemic anabolic environment to maximize the local repair effects of these peptides.
• For Testosterone Support & PCT: Pair with natural testosterone optimizers like Testagen 20 mg or during Post Cycle Therapy with Enclomiphene. Improved GH levels support overall endocrine health and recovery.

POST CYCLE THERAPY (PCT)

Sermorelin itself does not suppress the HPTA and is not a traditional PCT drug for testosterone. However, it can be a valuable adjunct in a comprehensive PCT protocol. The end of an anabolic cycle is a catabolic period where recovery is paramount. Using Sermorelin during PCT (for 8-12 weeks) can help maintain a positive nitrogen balance, support connective tissue health, improve sleep (which is often disrupted post-cycle), and provide a general anabolic boost that aids in retaining muscle mass as natural testosterone production restarts. It should be used alongside, not instead of, SERMs like Clomid or Nolvadex.

SIDE EFFECTS

Sermorelin is generally very well-tolerated with a low incidence of side effects, especially when compared to direct GH injection.

• Injection Site Reactions: Mild redness, itching, or discomfort.
• Transient Flushing/Warmth: A brief feeling of warmth or facial flushing shortly after injection.
• Headache or Dizziness: Rare and usually mild, often related to the vasodilatory effect.
• Increased Hunger: Mild stimulation of appetite, particularly with higher doses, as GH can affect metabolism.
• Numbness/Tingling (Carpal Tunnel-like symptoms): Extremely rare at recommended doses; this is more common with direct high-dose GH.

Notably absent are the significant water retention, joint pain, insulin resistance, and suppression of natural GH production associated with exogenous GH. There is no androgenic or estrogenic activity.

CONTRAINDICATIONS

Contraindications include:

• Known hypersensitivity to Sermorelin or any component of the formulation.
• Active malignancy (cancer). GH can promote the growth of certain tumors.
• Pituitary tumor or acromegaly.
• Critical illness or complications following open heart or abdominal surgery, multiple accidental trauma, or acute respiratory failure.
• Pregnancy and breastfeeding (due to lack of safety data).

OVERDOSE

Acute overdose is unlikely to be life-threatening. Symptoms would be an amplification of side effects: significant flushing, headache, nausea, and possibly low blood pressure. Chronic overdose through extremely high daily dosing could theoretically lead to symptoms of GH excess (acromegaly) or downregulation of pituitary GHRH receptors. Management involves discontinuation and supportive care. The effects are reversible upon cessation.

WARNINGS AND SPECIAL PRECAUTIONS FOR USE

This product is for research purposes only. It is not approved for human consumption as a drug. Important considerations:

• Neoplasm Screening: Should not be used in patients with active or suspected tumors. GH can stimulate growth of certain cancerous cells.
• Diabetes & Glucose Intolerance: Monitor blood glucose levels, as GH has anti-insulin effects. Individuals with diabetes should use with extreme caution and under medical supervision.
• Thyroid Function: Prolonged GH increase can alter thyroid hormone metabolism. Monitoring of thyroid function may be advisable during long cycles.
• Pituitary Function: While Sermorelin stimulates the pituitary, very long-term use without breaks could theoretically lead to receptor desensitization. Cycling is recommended.
• Sterile Technique: Imperative to prevent infection. Use only Bacteriostatic Water for multi-dose vials.

INTERACTIONS WITH OTHER DRUGS

• Glucocorticoids (e.g., Cortisone, Prednisone): May inhibit the growth-promoting effects of Sermorelin.
• Cyclosporine: Sermorelin may increase blood levels of cyclosporine, requiring monitoring.
• Other GH-Releasing Agents (GHRPs like Ipamorelin, Hexarelin): Concomitant use has a powerful synergistic effect, increasing GH release significantly.
• Insulin and Oral Hypoglycemics: GH can cause insulin resistance. Diabetic patients may need to adjust their medication dosage.
• Sex Hormones (Estrogen, Androgens): Estrogen can blunt the GH response to GHRH. High androgen levels may influence IGF-1 production.

PRESENTATION, PACKAGING

Dragon Pharma Sermorelin 5 mg is presented in professional, discreet packaging. Each box contains one 2 mL clear glass vial. The vial is sealed with a bromobutyl rubber stopper and a tamper-evident aluminum flip-off cap. The label clearly displays the Dragon Pharma logo, product name "Sermorelin," strength "5 mg," batch number, expiration date, and storage instructions. The packaging protects the lyophilized powder from light and physical damage.

STORAGE

• Before Reconstitution: Store the sealed vial in a refrigerator at 2°C to 8°C (36°F to 46°F). For short periods (under 30 days), a cool, dark place below 25°C (77°F) is acceptable. Avoid freezing.
• After Reconstitution: The reconstituted solution must be stored in the refrigerator immediately at 2°C to 8°C (36°F to 46°F). It remains stable and potent for up to 14-21 days when refrigerated. Do not freeze the reconstituted solution. Discard if cloudiness or precipitation occurs.

DELIVERY TO THE USA

We offer fast, reliable, and discreet shipping to all 50 states. Orders are processed within 24-48 hours and shipped in plain, unmarked packaging. Tracking information is provided upon shipment. Delivery within the continental USA typically takes 3-7 business days. All transactions are secured with advanced SSL encryption to protect your personal and payment information.

LEGAL STATUS

Sermorelin is a peptide that is not classified as a controlled substance under U.S. federal law. It was previously an FDA-approved drug (Geref®) for diagnostic use in children. It is now available as a compounded peptide and for research. This product is sold explicitly for laboratory research purposes. The buyer assumes all responsibility for compliance with local, state, and federal laws regarding its purchase, possession, and use.

DATE OF LAST TEXT CHECKS

/

NAME AND ADDRESS OF THE MANUFACTURER

Dragon Pharma, Europe

EXTERNAL LINKS

• NIH/PubMed - Clinical study on the efficacy and safety of Sermorelin in stimulating GH release and its physiological effects.
• NIH/PubMed - Review on the role of GHRH and its analogs (like Sermorelin) in aging and age-related diseases.

PROFILE

• Chemical name: Sermorelin Acetate (GHRH (1-29))
• Chemical formula: C₁₄₉H₂₄₆N₄₄O₄₂S
• Percentage of anabolic activity: Low indirect anabolic activity via IGF-1 stimulation.
• Percentage of androgenic activity: 0% (Non-androgenic).
• Active half life: Approximately 10-20 minutes in serum, but induces a GH pulse with effects lasting hours.
• Recommended dosage: 100 mcg to 300 mcg (0.1 mg to 0.3 mg) injected subcutaneously once daily before bed.
• Acne: Rare, not a typical side effect.
• Bloating (water retention): Minimal to none; significantly less than exogenous GH.
• HBR (High Blood Pressure): No direct hypertensive effect; may cause transient vasodilation.
• Hepatic toxicity: None reported.
• Aromatization: Does not aromatize (does not convert to estrogen).